Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Cancer Therapy-Related Diarrhea
×
Other solid neoplasm
×
Clear all
Filters
3
NCT04538625
2024-07-26
OnTARGET
Napo Pharmaceuticals, Inc.
Phase 3
Completed
287 enrolled